FDA warning letter · Drugs

Media Networks Sydney Pty Limited

Issued · Posted by FDA

FDA published a close-out letter on Sep 23, 2024. The passages below are from the original warning letter.

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

the active ingredients included in the package labeling are aluminum hydroxide, magnesium hydroxide, and simethicone. However, the electronic listing file only includes aluminum hydroxide and dimethiconol as the active ingredients while including magnesium hydroxide as an inactive ingredient.

Passage 2

the active ingredients described in the package labeling include sodium citrate, sodium lauryl sulfoacetate, and sorbitol. However, the electronic listing file only includes sorbitol as the active ingredient and sodium lauryl sulfoacetate and sodium citrate (trisodium citrate dihydrate) as inactive ingredients.

Citations in the original letter

As cited in this historical letter, not a statement of current regulatory requirements.

  • 21 CFR 207.49(a)(4)
  • 21 CFR 207.57(b)(2)
  • 21 CFR 207.33(c)
  • 21 CFR 207